Close watch on this pos, Does Chiasma Inc Have
Post# of 23065
Posted On: 05/14/2016 10:18:44 PM
Close watch on this pos,
Does Chiasma Inc Have Any Gas After Today’s Huge Increase?
Donnie PowellMay 14, 2016
Like
The stock of Chiasma Inc (NASDAQ: $CHMA ) is a huge mover today! The stock increased 3.92% or $0.1 during the last trading session, hitting $2.65. About 548,754 shares traded hands. Chiasma Inc (NASDAQ:CHMA) has declined 87.85% since October 8, 2015 and is downtrending. It has underperformed by 89.50% the S&P500. The move comes after 9 months positive chart setup for the $56.22 million company. It was reported on May, 14 by Barchart.com. We have $5.99 PT which if reached, will make NASDAQ:CHMA worth $70.84M more.
Out of 4 analysts covering Chiasma (NASDAQ:CHMA), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Chiasma has been the topic of 5 analyst reports since August 10, 2015 according to StockzIntelligence Inc.
According to Zacks Investment Research, “Chiasma, Inc. is a biopharmaceutical company. The company’s TPE(R) technology develops oral peptides and other molecules. Its primary product candidate consists of oral octreotide which is in different clinical trial. Chiasma, Inc. is based in Newton, USA.”
Does Chiasma Inc Have Any Gas After Today’s Huge Increase?
Donnie PowellMay 14, 2016
Like
The stock of Chiasma Inc (NASDAQ: $CHMA ) is a huge mover today! The stock increased 3.92% or $0.1 during the last trading session, hitting $2.65. About 548,754 shares traded hands. Chiasma Inc (NASDAQ:CHMA) has declined 87.85% since October 8, 2015 and is downtrending. It has underperformed by 89.50% the S&P500. The move comes after 9 months positive chart setup for the $56.22 million company. It was reported on May, 14 by Barchart.com. We have $5.99 PT which if reached, will make NASDAQ:CHMA worth $70.84M more.
Out of 4 analysts covering Chiasma (NASDAQ:CHMA), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Chiasma has been the topic of 5 analyst reports since August 10, 2015 according to StockzIntelligence Inc.
According to Zacks Investment Research, “Chiasma, Inc. is a biopharmaceutical company. The company’s TPE(R) technology develops oral peptides and other molecules. Its primary product candidate consists of oral octreotide which is in different clinical trial. Chiasma, Inc. is based in Newton, USA.”
(1)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'